Skip to content
Clinical Trials – home

Dexmedetomidine Hydrochloride: A Comprehensive Guide for Patients

0 / 1
trials open to patients / all trials
1+
Countries

In short

Dexmedetomidine Hydrochloride, also known by the brand name Precedex, is being studied in various clinical trials for its potential benefits in sedation and pain management. This article will explore how this drug is being investigated for use in different patient populations and medical procedures, from pediatric intensive care to surgical settings. We'll look at its effects on sedation levels, pain control, and overall patient outcomes based on recent clinical research.

At a glance

Primary Uses in Trials
Sedation in pediatric ICU, procedural sedation, post-operative pain management, cough suppression during anesthesia emergence
Administration Methods
Intravenous infusion, intranasal administration (in some trials)
Dosage Ranges
Varies by age and use; typically 0.2-1.4 μg/kg/hr for infusions
Patient Populations
Infants (45 weeks corrected gestational age) to adults; focus on pediatric and surgical patients
Potential Benefits
Improved sedation control, reduced need for other medications, decreased coughing, possible anti-inflammatory effects
Monitored Side Effects
Changes in heart rate, blood pressure, respiratory function; potential withdrawal symptoms; skin reactions at infusion sites
Key Outcome Measures
Sedation effectiveness, pain control, hemodynamic stability, recovery time, patient comfort

What is Dexmedetomidine?

Dexmedetomidine hydrochloride, also known simply as dexmedetomidine or by the brand name Precedex, is a medication used primarily for sedation in medical settings. It belongs to a class of drugs called alpha-2 adrenergic agonists, which means it works on specific receptors in the brain to produce its effects.

Uses of Dexmedetomidine

Dexmedetomidine is used in various medical scenarios, including:

  • Sedation in intensive care units (ICUs): It's used to keep patients calm and comfortable while on mechanical ventilation (a machine that helps with breathing).
  • Procedural sedation: It's used to sedate patients for various medical procedures, especially in children.
  • Anesthesia adjunct: It's sometimes used alongside other anesthesia medications during surgeries.
  • Management of agitated delirium: It's being studied for use in patients with severe confusion and agitation, particularly in palliative care settings.

How Dexmedetomidine Works

Dexmedetomidine works by activating alpha-2 receptors in the brain. This action has several effects:

  • Sedation: It produces a calm, sleepy state without causing deep unconsciousness. Patients can often still be awakened and respond to commands.
  • Pain relief: It has some pain-relieving (analgesic) properties, which can help reduce the need for other pain medications.
  • Anxiety reduction: It can help reduce anxiety and stress.

How Dexmedetomidine is Administered

Dexmedetomidine is typically given in one of these ways:

  • Intravenous (IV) infusion: This is the most common method, where the medication is given slowly through a vein.
  • Intranasal administration: In some cases, especially for children, it may be given as a nasal spray.
  • Subcutaneous infusion: In certain situations, it may be given under the skin.

The dosage and duration of administration depend on the specific use and the patient's individual characteristics.

Benefits of Dexmedetomidine

Dexmedetomidine offers several potential benefits:

  • Rousable sedation: Unlike some other sedatives, patients on dexmedetomidine can often be awakened easily, which can be beneficial in certain medical situations.
  • Reduced need for opioids: It can help reduce the amount of opioid pain medication needed, which may decrease side effects associated with opioids.
  • Minimal respiratory depression: Unlike some other sedatives, dexmedetomidine doesn't significantly suppress breathing.
  • Potential anti-inflammatory effects: Some research suggests it may help reduce inflammation in the body.

Potential Side Effects

Like all medications, dexmedetomidine can cause side effects. Common ones include:

  • Bradycardia: Slowing of the heart rate.
  • Hypotension: Low blood pressure.
  • Nausea and vomiting.
  • Dry mouth.

In most cases, these side effects are manageable and resolve when the medication is stopped. However, patients are closely monitored when receiving dexmedetomidine, especially for changes in heart rate and blood pressure.

Ongoing Research

Researchers are continually studying dexmedetomidine to understand its full potential. Current areas of investigation include:

  • Use in pediatric patients: Studies are looking at its safety and effectiveness in children for various procedures.
  • Management of agitated delirium: Its potential in helping patients with severe confusion and agitation is being explored.
  • Pain management after surgery: Its role in reducing pain and opioid use after operations is under investigation.
  • Immunomodulatory effects: Some studies are looking at how it might affect the immune system.

As research continues, we may discover new uses and benefits of dexmedetomidine in medical care.

Questions people often ask

Conditions where Dexmedetomidine Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Dexmedetomidine Hydrochloride

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).